Masimo Corporation (NASDAQ:MASI) Given Average Recommendation of “Hold” by Analysts

Shares of Masimo Corporation (NASDAQ:MASI) have been assigned a consensus recommendation of “Hold” from the nine analysts that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $181.1667.

Several analysts have issued reports on MASI shares. Piper Sandler cut Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price objective on the stock. in a research note on Tuesday, February 17th. Wells Fargo & Company raised Masimo to a “hold” rating in a report on Wednesday, March 18th. Stifel Nicolaus set a $180.00 target price on Masimo in a research report on Tuesday, February 17th. Wolfe Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a report on Thursday, February 19th. Finally, BTIG Research lowered Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th.

Institutional Trading of Masimo

Institutional investors and hedge funds have recently modified their holdings of the business. Global Retirement Partners LLC bought a new position in shares of Masimo in the 4th quarter worth about $27,000. Aster Capital Management DIFC Ltd bought a new stake in shares of Masimo during the 4th quarter valued at about $28,000. Los Angeles Capital Management LLC bought a new stake in shares of Masimo during the 4th quarter valued at about $31,000. MAI Capital Management raised its stake in Masimo by 176.7% during the second quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 129 shares during the period. Finally, Rothschild Investment LLC raised its stake in Masimo by 12,950.0% during the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after acquiring an additional 259 shares during the period. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Stock Performance

Shares of Masimo stock opened at $176.89 on Friday. The firm has a market cap of $9.50 billion, a PE ratio of -16.78, a price-to-earnings-growth ratio of 1.80 and a beta of 1.21. Masimo has a 1 year low of $125.94 and a 1 year high of $179.00. The firm’s 50-day simple moving average is $159.23 and its 200-day simple moving average is $148.12. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.47 and a current ratio of 2.49.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.